AstraZeneca Announces Groundbreaking $50 Billion US Investment by 2030 for Drug Innovation

AstraZeneca PLC plans a $50 billion investment in the US by 2030, focusing on a new AI-driven drug manufacturing facility in Virginia and expanding R&D centers nationwide. This str...